There\u2019s no doubt endovascular therapy has revolutionized the treatment of cardiovascular complications. What once required invasive surgery can now be treated by working through blood vessels inside the body, using specialist devices created for this work.<\/p>\n
Such minimally invasive medical techniques have become a rapidly developing area of vascular surgery globally. According to the Vascular Society for Great Britain and Ireland<\/a>, demand is set to rise 67% by 2029.<\/p>\n Endovascular treatment provides benefits for both the medical sector, and the patient. Due to less severe surgery, hospital stays are shorter, which means less resources have to be allocated to each patient. For the patient, recovery time is generally faster and less painful, due to less stress on the heart and smaller incisions to heal. Meanwhile, and most importantly, research suggests long term survival outcomes are better.<\/p>\n The challenge beyond the heart The challenge grows when we consider other parts of the body, such as the feet<\/a>, to treat peripheral arterial disease (it is estimated that over 200 million people worldwide suffer from this condition), or the brain<\/a>, to prevent or treat stroke.<\/p>\n Blood vessels in the foot are much smaller and notoriously difficult to navigate. It\u2019s not always a straight access and calcification can be worse in these more restricted parts of the body. The same challenges exist when accessing the brain.<\/p>\n Even with these challenges, research has shown that endovascular intervention in these areas have highly successful outcomes:<\/p>\n <\/b><\/p>\n These endovascular interventions are only becoming possible with the development of highly innovative and intricate microcatheters. Devices must be incredibly tiny and nimble to accurately traverse these miniscule areas of the body, safely and effectively.<\/p>\n With this in mind, I\u2019m sure you\u2019ll wholeheartedly agree that the need for catheter innovation to keep pace is clear. Catheters must combine a multitude of properties and functions to serve the increased and wider use of endovascular treatment. They must be incredibly strong and flexible, whilst tiny enough to safely access the far reaches of the body, such as below the knee and above the neck. It\u2019s no small feat!<\/p>\n Minuscule catheter liners with superior strength and flexibility Essentially, StreamLiner\u2122 catheter liners enable device engineers to build microcatheters which can safely reach more parts of the body \u2013 even via the smallest vasculatures and the most complex anatomies.<\/p>\n The StreamLiner\u2122 series enables new limb and life-saving therapies to become possible. Endovascular treatment will accelerate with access to the right tools.\u00a0<\/strong><\/p>\n Clinicians enjoy huge benefits from catheters built with such tiny catheter liners:<\/p>\n Not only are StreamLiner\u2122 liners stronger, they offer greater pushability whilst remaining kink resistant.<\/p>\n I\u2019m incredibly proud to say that customer feedback about StreamLiner\u2122 liners has been incredibly positive. The next generation of microcatheters is now a reality \u2013 it\u2019s a game-changing development.<\/p>\n StreamLiner\u2122 liners are helping to keep our customers at the forefront of catheter design. It\u2019s an incredible advantage that provides meaningful benefits to medical teams and society as a whole.<\/p>\n Stories of innovation & StreamLiner\u2122 use cases Endovascular Interventions: Below-the-knee<\/em><\/a> Endovascular Interventions: The brain<\/em> <\/a> Order your StreamLiner\u2122 samples As a partner to medical device OEMs globally, we\u2019re here to help and would love to discuss any projects you\u2019re working on.<\/p>\n
\n<\/span> <\/strong>Until fairly recently, endovascular treatment mainly focused on treating those at risk of heart attacks and other cardiovascular conditions such as aneurysms and thoracic aortic diseases. Veins and arteries are larger in this area of the body \u2013 it\u2019s easier to precisely navigate a catheter to where a stent is required.<\/p>\n\n
\n<\/span> <\/strong>Many of our customers are at the forefront of catheter design and manufacture. It was clear they needed our help where intricate catheter liners were concerned. And so, we worked with them to create the PTFE StreamLiner\u2122 series<\/a>.\u00a0<\/strong><\/p>\n\n
\n<\/span> <\/strong>Read our stories of innovation to further understand how StreamLiner\u2122 is supporting endovascular treatment in the far reaches of the body:<\/p>\n
\nTreatment for PAD patients who fail conservative management has traditionally been surgical revascularization. However, there is increasing evidence to support endovascular intervention in patients where in-line flow to the foot can be re-established. Despite advances, routine below-the-knee peripheral vascular intervention is limited as a result of a lack of interventional devices of appropriate length, strength, thickness, diameter, and flexibility.<\/p>\n
\n<\/u>The brain, with its tiny blood vessels and highly tortuous arteries, presents a unique challenge for catheter engineers: designing a catheter with the right combination of properties which can more easily access and navigate the vasculature of the brain, without sacrificing torque, pushability, and trackability \u2013 to open up new pathways and delivering life- saving treatments.<\/p>\n
\n<\/span> <\/strong>Should you want to see our catheter liners for yourself, please contact us here<\/a> and we\u2019ll arrange some free samples for you.<\/p>\n